Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS (2025)
Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050

Taskén K, Mahon P (2025)
Accelerating precision oncology by converging pragmatic trials and real-world evidence
Nat Rev Drug Discov (in press)
DOI 10.1038/d41573-025-00047-5, PubMed 40082591

Avershina E, Qureshi AI, Winther-Larsen HC, Rounge TB (2025)
Challenges in capturing the mycobiome from shotgun metagenome data: lack of software and databases
Microbiome, 13 (1), 66
DOI 10.1186/s40168-025-02048-3, PubMed 40055808

Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS (2025)
Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050

Taskén K, Mahon P (2025)
Accelerating precision oncology by converging pragmatic trials and real-world evidence
Nat Rev Drug Discov (in press)
DOI 10.1038/d41573-025-00047-5, PubMed 40082591

Lindemann K, Siegenthaler F, Lande KT, Casas-Arozamena C, Nebdal D, Rau TT, Hoivik EA, Mueller MD, Gold RM, Imboden S, Davidson B, Krakstad C, Sørlie T (2025)
Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study
Gynecol Oncol, 195, 98-105 (in press)
DOI 10.1016/j.ygyno.2025.03.002, PubMed 40081113